- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Profitable Climbers
Norwegian Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
Photocure
Market Cap: NOK 2.0b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 74.60
7D
4.5%
1Y
27.1%
ArcticZymes Technologies
Market Cap: NOK 1.2b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 23.80
7D
15.5%
1Y
67.4%